Yan Ling Cao
Director/Board Member bij OCUMENSION THERAPEUTICS
Profiel
Yan Ling Cao is Partner & Member at Boyu Capital Group Management Ltd.
and on the board of 8 other companies.
In the past he was Senior Investment Manager at General Atlantic LLC (China) and Senior Investment Analyst at General Atlantic Asia Ltd.
He received an undergraduate degree from Middlebury College.
Actieve functies van Yan Ling Cao
Bedrijven | Functie | Begin |
---|---|---|
WUXI BIOLOGICS (CAYMAN) INC. | Director/Board Member | 01-05-2016 |
WUXI PHARMATECH (CAYMAN) INC. (ADR) | Director/Board Member | - |
OCUMENSION THERAPEUTICS | Director/Board Member | 18-06-2019 |
Boyu Capital Group Management Ltd. | Corporate Officer/Principal | 01-03-2011 |
Life Science Holdings, Inc. | Director/Board Member | - |
LifeMine Therapeutics, Inc.
LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Director/Board Member | - |
Wuxi New Life Science Investment Ltd.
Wuxi New Life Science Investment Ltd. Financial ConglomeratesFinance Wuxi New Life Science Investment Ltd. is a Chinese company that provides investment services. The private company is based in Shanghai, China. | Director/Board Member | - |
Wuxi Nextcode Holdings Ltd.
Wuxi Nextcode Holdings Ltd. Financial ConglomeratesFinance Wuxi Nextcode Holdings Ltd. functions as an investment holding There is no available country named vg company. | Director/Board Member | - |
Wuxi Biologics Holdings Ltd.
Wuxi Biologics Holdings Ltd. Financial ConglomeratesFinance Wuxi Biologics Holdings Ltd. functions as an investment holding There is no available country named vg company. | Director/Board Member | - |
Eerdere bekende functies van Yan Ling Cao
Bedrijven | Functie | Einde |
---|---|---|
░░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Opleiding van Yan Ling Cao
Middlebury College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 8 |
---|---|
WUXI APPTEC CO., LTD. | Health Technology |
GAN & LEE PHARMACEUTICALS. | Health Technology |
CSTONE PHARMACEUTICALS | Health Technology |
WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
JW (CAYMAN) THERAPEUTICS CO. LTD | Health Technology |
OCUMENSION THERAPEUTICS | Health Technology |
HYGEIA HEALTHCARE HOLDINGS CO., LIMITED | Health Technology |
ANTENGENE CORPORATION LIMITED | Health Technology |
Bedrijven in privébezit | 12 |
---|---|
Wuxi PharmaTech (Cayman), Inc.
Wuxi PharmaTech (Cayman), Inc. Pharmaceuticals: MajorHealth Technology Wuxi PharmaTech (Cayman), Inc. engages in the provision of research and development outsourcing services for the pharmaceutical, biotechnology and medical device industries. It operates through the laboratory services and manufacturing services segments. The laboratory services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The manufacturing services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang and Ning Zhao in 2000 and is headquartered in Shanghai, China. | Health Technology |
General Atlantic Asia Ltd.
General Atlantic Asia Ltd. Investment ManagersFinance General Atlantic Asia Ltd. is a Private Equity/Venture Capital firm, a subsidiary of General Atlantic LLC founded in 2007. General Atlantic Asia Ltd. is headquartered in Hong Kong. | Finance |
Life Science Holdings, Inc. | |
General Atlantic LLC (China) | Finance |
LifeMine Therapeutics, Inc.
LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Health Technology |
Wuxi Biologics Holdings Ltd.
Wuxi Biologics Holdings Ltd. Financial ConglomeratesFinance Wuxi Biologics Holdings Ltd. functions as an investment holding There is no available country named vg company. | Finance |
Antengene Corporation Co., Ltd.
Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Health Technology |
Wuxi New Life Science Investment Ltd.
Wuxi New Life Science Investment Ltd. Financial ConglomeratesFinance Wuxi New Life Science Investment Ltd. is a Chinese company that provides investment services. The private company is based in Shanghai, China. | Finance |
Wuxi Nextcode Holdings Ltd.
Wuxi Nextcode Holdings Ltd. Financial ConglomeratesFinance Wuxi Nextcode Holdings Ltd. functions as an investment holding There is no available country named vg company. | Finance |
Boyu Capital Group Management Ltd. | |
Viela Bio, Inc.
Viela Bio, Inc. BiotechnologyHealth Technology Viela Bio, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatment for autoimmune and inflammatory diseases. The firms product candidate includes inebilizumab, which is a humanized monoclonal antibody (mAb), designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells; VIB4920, which is a fusion protein designed to bind to CD40L on activated T cells, blocking their interaction with CD40-expressing B cells and potentially other binding partners; and VIB7734, which is a humanized mAb intended to be a novel treatment for autoimmune diseases where the pathology is driven principally by overproduction of type I interferons and other cytokines secreted by pDCs. The company was founded on December 11, 2017 and is headquartered in Gaithersburg, MD. | Health Technology |
Fujian Herui Gene Technology Co., Ltd.
Fujian Herui Gene Technology Co., Ltd. BiotechnologyHealth Technology Fujian Herui Gene Technology Co. Ltd. provides biotechnological services. It mainly engages in the medical research & experimental development, biotechnology equipment leasing and medical testing services. The company was founded on August 17, 2017 and is headquartered in Fuzhou, China. | Health Technology |